BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15982332)

  • 1. Paraganglion of the prostate gland: an uncommon mimic of prostate cancer in needle biopsies.
    Howarth SM; Griffiths DF; Varma M
    Histopathology; 2005 Jul; 47(1):114-5. PubMed ID: 15982332
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraganglia of the prostate. Location, frequency, and differentiation from prostatic adenocarcinoma.
    Ostrowski ML; Wheeler TM
    Am J Surg Pathol; 1994 Apr; 18(4):412-20. PubMed ID: 8141432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraganglion of the prostate in a needle biopsy: a potential diagnostic pitfall.
    Kawabata K
    Arch Pathol Lab Med; 1997 May; 121(5):515-6. PubMed ID: 9167608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endocrine differentiated prostate cancer. Histology and immunohistochemistry].
    Helpap B; Oehler U; Bollmann R
    Pathologe; 1990 Jan; 11(1):18-24. PubMed ID: 1690418
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical study of chromogranin A in Stage D2 prostate cancer.
    Kokubo H; Yamada Y; Nishio Y; Fukatsu H; Honda N; Nakagawa A; Saga S; Tsuzuki T; Hara K
    Urology; 2005 Jul; 66(1):135-40. PubMed ID: 15992907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer.
    Schowinsky JT; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):866-70. PubMed ID: 16819329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in prostate cancer.
    Shariff AH; Ather MH
    Urology; 2006 Jul; 68(1):2-8. PubMed ID: 16844446
    [No Abstract]   [Full Text] [Related]  

  • 8. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the value of fine needle aspiration biopsy of the prostate.
    Buhmeida A; Collan Y
    Pathologica; 2001 Jun; 93(3):242-3. PubMed ID: 11433620
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J; Hanchanale V; Foster CS; Javlé P
    BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores.
    Rochester MA; Griffin S; Chappell B; McLoughlin J
    Urol Int; 2009; 83(2):155-9. PubMed ID: 19752609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Kumar V
    BJU Int; 2007 Jan; 99(1):209-10; author reply 210. PubMed ID: 17227502
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H; Nonomura N; Nishimura K; Oka D; Shiba M; Nakai Y; Nakayama M; Tsujimura A; Aozasa K; Okuyama A
    BJU Int; 2009 Feb; 103(4):470-4. PubMed ID: 18778349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraganglia of the gallbladder: a report of two cases with an immunohistochemical study.
    Kawabata K
    Pathol Res Pract; 1999; 195(11):781-6. PubMed ID: 10605699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
    Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
    Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse p63 positivity in prostate cancer: a mimic of prostatic atrophy.
    Rao P; Dwyer M; Mikel J; Varma M
    Histopathology; 2012 Apr; 60(5):847-8. PubMed ID: 22260619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.